EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

Lynn Al Samra iD, Mohamad El Nahas, Ilham Mneimneh, Sima Tokajian, Georges Nemer, Aia Sinno, Kelven Rahy, Sergio Thoumi, Zahraa Zibara, Ahmad El Khatib, Dalal Sabbagh, Jacques Guillot iD und 4 weitere

Parasite · 2025

DOI: 10.1051/parasite/2025035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasite, 2025. Verfasst von Lynn Al Samra und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut Campus, P.O. Box 13-5053, Chouran, 1102 2801 Beirut…. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Macrolides, Leishmania tropica, Drug Repositioning. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lebanese American University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous leishmaniasis presents a significant challenge to public health due to its diverse clinical manifestations, resistance development, and treatment-related adverse effects. Here, we examined the efficacy of ivermectin, moxidectin (MOX), afoxolaner, and permethrin against all stages of Leishmania tropica and THP-1 cells. We also assessed the potential for resistance acquisition after 15 rounds of artificial selection. To elucidate the mode of action of MOX, we employed RNA sequencing, molecular dynamics simulation, and chloride flux assays. Additionally, we evaluated the therapeutic index of MOX using the Galleria mellonella infection model. MOX demonstrated the highest selectivity index against leishmaniasis (promastigotes: 0.58 μM; amastigotes: 0.96 μM; host cells: 60.29 μM). Moreover, MOX exhibited the lowest resistance acquisition in both promastigotes and intracellular amastigotes after 15 rounds of artificial selection, with resistance ratios of 17.23 and 4.59, respectively. Post-exposure to MOX, differential gene expression profiles showed both stage-specific and stage-unspecific enrichment of gene families involved in crucial biological processes. Moreover, molecular dynamics simulations revealed a potential neutralizing effect of MOX on the chloride channel of L. tropica . Specifically, MOX binds to the selectivity filter, potentially disrupting the osmotic equilibrium and thereby killing the parasite. The in vivo introduction of MOX significantly inhibited the growth of L. tropica in G. mellonella larvae, resulting in decreased rates of mortality and melanization. These findings indicate that MOX is a promising candidate for the treatment of L. tropica infections, warranting further investigation and potential consideration for clinical use .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, CutaneousMacrolidesLeishmania tropicaDrug RepositioningAntiprotozoal AgentsAnimalsHumansMolecular Dynamics SimulationDrug ResistanceMothsIvermectinCell LinePermethrin

Stichwörter der Autor:innen

Drug repurposingDrug resistanceLeishmaniaMoxidectinRNA-Seqleishmaniasis

Substanzen

moxidectinMacrolidesAntiprotozoal AgentsIvermectinPermethrin

Autor:innen und Institutionen

  • Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut Campus, P.O. Box 13-5053, Chouran, 1102 2801 Beirut, Lebanon.
  • Department of Computer Science and Mathematics, Lebanese American University, Beirut Campus, P.O. Box 13-5053, Chouran, 1102 2801 Beirut, Lebanon.
  • Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Byblos Campus, P.O. Box 36, Byblos, Lebanon.
  • Division of Genomics and Translational Biomedicine, College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 34110 Doha, Qatar.
  • Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos Campus, P.O. Box 36, Byblos, Lebanon.
  • Oniris VetAgroBio, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique, Campus de la Chantrerie, 101 Route de Gachet, 44307 Nantes Cedex 3, France - IRF, IRCAT, Université d'Angers, UBO,…

ORCID-Profile: Lynn Al Samra, Jacques Guillot, Charbel Al Khoury

Förderung

  • Lebanese American University

Zitieren

APA

Al Samra, L., El Nahas, M., Mneimneh, I., Tokajian, S., Nemer, G., Sinno, A., Rahy, K., Thoumi, S., Zibara, Z., El Khatib, A., Sabbagh, D., Guillot, J., Karam, L., Ali, L., Baghdadi, R., & Al Khoury, C. (2025). Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy. Parasite. https://doi.org/10.1051/parasite/2025035

Vancouver

Al Samra L, El Nahas M, Mneimneh I, Tokajian S, Nemer G, Sinno A, et al. Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy. Parasite. 2025. doi:10.1051/parasite/2025035

BibTeX
@article{AlSamra2025,
  author = {Al Samra, Lynn and El Nahas, Mohamad and Mneimneh, Ilham and Tokajian, Sima and Nemer, Georges and Sinno, Aia and Rahy, Kelven and Thoumi, Sergio and Zibara, Zahraa and El Khatib, Ahmad and Sabbagh, Dalal and Guillot, Jacques and Karam, Louna and Ali, Lazo and Baghdadi, Ruqaya and Al Khoury, Charbel},
  title = {Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy},
  journal = {Parasite},
  year = {2025},
  doi = {10.1051/parasite/2025035}
}
Kostenlos starten →